Market Overview

Notable Options Activity in BAX

Shares of Baxter International(NYSE: BAX) are lower on the session by 6.6%, currently trading at $54.20. The stock is down due to a delay announced by the FDA regarding its immune drug HyQ. Baxter is co-producing the drug with Halozyme.

Options volatility is up significantly on the day with the April vol +7.0 and the May vol +4.4 points.. The strike seeing the heaviest action is the May 2012 $55.00 put, which has traded over 7,000 times on open interest of 11,000 contracts.

Baxter International Inc. (Baxter,) is a global healthcare company. Baxter and its subsidiaries develop, manufacture and market products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Posted-In: News Options FDA Markets Trading Ideas

 

Related Articles (BAX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters